141 Stories, most recent news story added Wed Dec 9, 10:53 am ET
A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1 (avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies.
WEST HAVEN, Conn.----NanoViricides, Inc. , announced today that the Company’s President, Anil R. Diwan, PhD, has been invited to give a talk at the Nano and Green Tech 2009 Conference on November 18, 2009 .
SAN DIEGO----Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
LONDON----Immune Targeting Systems Ltd, whose synthetic universal influenza-A vaccine enters clinical trials in 2010, today announced that Ken Powell has joined the board as non-executive Chairman.
Sinovac Biotech Ltd. , a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009.
In a way, it’s hard not to admire influenza.
AUGUSTA, Maine -- Two more deaths linked to H1N1 influenza in Maine were reported by the Maine Center for Disease Control and Prevention over the weekend, bringing the overall total to five since August.
LEBANON — The past year has been a banner one for Samaritan Lebanon Community Hospital, due in large part to the generosity ofthe community and staff members, CEO Becky Pape said Thursdayevening during the hospital’s annual M Club banquet andmeeting.
MONMOUTH JUNCTION, NJ--(Marketwire - November 13, 2009) - MedaSorb Technologies Corporation ( OTCBB : MSBT ) and its wholly-owned subsidiary, CytoSorbents, Inc., provided an update of its clinical program. Dr. Phillip Chan, Chief Executive Officer, stated, "As we welcome many new investors to the company, I wanted to give a brief update on our European Sepsis Trial. As many know, MedaSorb has ...
There are 17 new articles published yesterday and 24 new articles today in PLoS ONE . As always, you should rate the articles , post notes and comments and send trackbacks when you blog about the papers. You can now also easily place articles on various social services (CiteULike, Mendeley, Connotea, Stumbleupon, Facebook and Digg) with just one click. Here are my own picks for the week - you go ...
( American Society for Cell Biology ) A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1 (avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies.
Computer screening reveals possible drugs the H1N1 and H5N1 flu viruses just wouldn’t be able to resist
Computer screening reveals possible drugs the H1N1 and H5N1 flu viruses just wouldn’t be able to resist
Dec. 8 (Bloomberg) -- Flu vaccine shortages in developing nations may destabilize global security should the H1N1 virus become more deadly, said David Heymann , a former deputy head of the World Health Organization.
Nov. 24 (Bloomberg) -- A fresh wave of bird flu outbreaks in Egypt, Indonesia, Vietnam and Thailand highlights the threat to public health caused by the H5N1 virus, which risks swapping genes with other influenza strains to spawn new variants, the World Health Organization in Manila said in a statement today.
Dec. 4 (Bloomberg) -- The World Health Organization, facing criticism that it exaggerated the threat of swine flu, said it’s too soon to decide whether the pandemic is more or less deadly than seasonal flu and comparing death rates may be misleading.
